Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| BDX | +32.20% | −0.52% | +3.20% | +10.55% | +20.30% | +34.47% | +43.82% | +6.58% | +9.28% |
| ONE-MEDTECH | −12.80% | +1.44% | +2.98% | +8.46% | +5.00% | +7.64% | −10.75% | +10.56% | −10.02% |
| UGH-SSF | +6.95% | +0.85% | +4.06% | +6.48% | +6.57% | +13.29% | +14.99% | +18.98% | +12.40% |
| SCBIHEALT(SSFE) | +12.60% | +3.34% | +6.78% | +8.27% | +11.10% | +23.33% | +17.20% | +28.90% | −1.84% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes BDX: money market or bond funds, or no holdings data yet
| UGH-SSF | SCBIHEALT(SSFE) | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 9.20% | 9.59% |
 Merck & | 5.45% | 6.49% |
 AstraZeneca | 4.34% | 5.99% |
 Intuitive Surgical | 2.89% | 4.32% |
 ABBVIE | 2.77% | 6.48% |
 Vertex Pharmaceuticals | 2.58% | 4.83% |
| Only in UGH-SSF | ||
 Johnson & Johnson | 4.98% | N/A |
 Unitedhealth Group | 4.36% | N/A |
 GSK | 2.80% | N/A |
 Edwards Lifesciences | 2.37% | N/A |
| Only in SCBIHEALT(SSFE) | ||
 Gilead Sciences | N/A | 5.08% |
 Thermo Fisher | N/A | 4.12% |
 Jazz Pharmaceuticals | N/A | 3.40% |
 argenx | N/A | 3.12% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| BDX | +32.20% | 26.88% | 1.20 |
| SCBIHEALT(SSFE) | +12.60% | 17.46% | 0.72 |
| UGH-SSF | +6.95% | 15.46% | 0.45 |
| ONE-MEDTECH | −12.80% | 21.26% | −0.60 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | BDX | ONE-MEDTECH | UGH-SSF | SCBIHEALT(SSFE) |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 236 million | 41.09 million | 10.22 million |
| Inception date | N/A | 25 Jan 2022 | 9 Sep 2014 | 29 Jun 2021 |
| Master fund | N/A | iShares U.S. Medical Devices ETF | กองทุน United Global Healthcare Fund | BNP Paribas Funds Health Care Innovators |
| Dividend policy | N/A | Does not pay | Does not pay | Pays |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 87.11% | 96.38% | 82.39% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1,000 THB | 0.01 THB | 1 THB |
| Subsequent purchase | N/A | 1,000 THB | 0.01 THB | 1 THB |
| Redemption (amount) | N/A | No minimum | 0.01 THB | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | No minimum |
| Balance (units) | N/A | 100 units | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 14:00 | 15:30 |
| Redemption paid | N/A | T+4 | T+5 | T+4 |
